Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
RENEWED: A follow-up study of the opicinumab phase 2 RENEW study in participants with acute optic neuritis.
Aktas O, Ziemssen F, Ziemssen T, Klistorner A, Butzkueven H, Izquierdo G, Leocani L, Balcer LJ, Galetta SL, Castrillo-Viguera C, Bradley DP, Naylor ML, Belachew S, Franchimont N, Zhu B, Cheng W; RENEWED Investigators. Aktas O, et al. Among authors: balcer lj. Mult Scler Relat Disord. 2024 Nov 24;93:106185. doi: 10.1016/j.msard.2024.106185. Online ahead of print. Mult Scler Relat Disord. 2024. PMID: 39662163 Free article.
Treatment of acute demyelinating optic neuritis.
Balcer LJ, Galetta SL. Balcer LJ, et al. Semin Ophthalmol. 2002 Mar;17(1):4-10. doi: 10.1076/soph.17.1.4.10287. Semin Ophthalmol. 2002. PMID: 15513449 Review.
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.
Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch L, Frederiksen J, Skeen M, Jaffe GJ, Butzkueven H, Ziemssen F, Massacesi L, Chai Y, Xu L, Freeman S; RENEW Study Investigators. Cadavid D, et al. Lancet Neurol. 2017 Mar;16(3):189-199. doi: 10.1016/S1474-4422(16)30377-5. Epub 2017 Feb 15. Lancet Neurol. 2017. PMID: 28229892 Clinical Trial.
Predictors of response to opicinumab in acute optic neuritis.
Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch LJ, Leocani L, Freedman MS, Plant GT, Preiningerova JL, Ziemssen F, Massacesi L, Chai Y, Xu L; RENEW Study Investigators. Cadavid D, et al. Among authors: balcer l. Ann Clin Transl Neurol. 2018 Aug 15;5(10):1154-1162. doi: 10.1002/acn3.620. eCollection 2018 Oct. Ann Clin Transl Neurol. 2018. PMID: 30349850 Free PMC article.
All choked up about the pseudotumor cerebri syndrome.
Galetta SL, Balcer LJ. Galetta SL, et al. Among authors: balcer lj. Neurology. 2013 Sep 24;81(13):1112-3. doi: 10.1212/WNL.0b013e3182a55ff7. Epub 2013 Aug 14. Neurology. 2013. PMID: 23946302
The neuro-ophthalmology of head trauma.
Ventura RE, Balcer LJ, Galetta SL. Ventura RE, et al. Among authors: balcer lj. Lancet Neurol. 2014 Oct;13(10):1006-16. doi: 10.1016/S1474-4422(14)70111-5. Lancet Neurol. 2014. PMID: 25231523 Review.
Acute optic neuritis: Unmet clinical needs and model for new therapies.
Galetta SL, Villoslada P, Levin N, Shindler K, Ishikawa H, Parr E, Cadavid D, Balcer LJ. Galetta SL, et al. Among authors: balcer lj. Neurol Neuroimmunol Neuroinflamm. 2015 Jul 23;2(4):e135. doi: 10.1212/NXI.0000000000000135. eCollection 2015 Aug. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 26236761 Free PMC article. Review.
302 results